Cell-free synthesis meets antibody production: A review

Antibodies

Volumn 4, Issue 1, 2015, Pages 12-33

  Stech, Marlitt ^a   Kubick, Stefan ^a  

^a FRAUNHOFER INSTITUTE FOR CELL THERAPY AND IMMUNOLOGY   (Germany)

Author keywords

Antibody; Antibody fragment; Cell free; Cell free protein synthesis; Disulfide bond formation; Eukaryotic lysate; Microsomal vesicles; scFv

Indexed keywords

AMINO ACID; ANTIBODY; CELL EXTRACT; DITHIOTHREITOL; GLUTATHIONE; HYBRID PROTEIN; IMMUNOGLOBULIN F (AB) FRAGMENT; IMMUNOGLOBULIN G1 ANTIBODY; LUCIFERASE; MESSENGER RNA; POLYPEPTIDE; RECOMBINANT ANTIBODY; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY; TRANSFER RNA; UNCLASSIFIED DRUG;

ANTIBODY PRODUCTION; CELL FREE SYSTEM; CELL LINE; CELL LYSATE; CYTOTOXICITY; DISULFIDE BOND; ESCHERICHIA COLI; EUKARYOTIC CELL; HUMAN; HYBRIDOMA; IMMUNOGENICITY; ISOMERIZATION; ISOTOPE LABELING; MAMMAL CELL; NONHUMAN; PHAGE DISPLAY; PRIORITY JOURNAL; PROKARYOTIC CELL; PROTEIN SYNTHESIS; REVIEW; RIBOSOME; RNA TRANSLATION; SPODOPTERA FRUGIPERDA 21 CELL;

EID: 85106461376     PISSN: 20734468     EISSN: None     Source Type: Journal    
DOI: 10.3390/antib4010012     Document Type: Review

References (124)

1. Hudson, P.; Souriau, C. Engineered antibodies. Nat. Med. 2003, 9, 129–134.
2. Hagemeyer, C.E.; von zur Muhlen, C.; von Elverfeldt, D.; Peter, K. Single-chain antibodies as diagnostic tools and therapeutic agents. Thromb. Haemost. 2009, 101, 1012–1019.
3. Goshima, N.; Kawamura, Y.; Fukumoto, A.; Miura, A.; Honma, R.; Satoh, R.; Wakamatsu, A.; Yamamoto, J.; Kimura, K.; Nishikawa, T et al. Human protein factory for converting the transcriptome into an in vitro-expressed proteome. Nat. Methods 2008, 5, 1011–1017.
4. Zawada, J.F.; Yin, G.; Steiner, A.R.; Yang, J.; Naresh, A.; Roy, S.M.; Gold, D.S.; Heinsohn, H.G.; Murray, C.J. Microscale to manufacturing scale-up of cell-free cytokine production—A new approach for shortening protein production development timelines. Biotechnol. Bioeng. 2011, 108, 1570–1578.
5. Stech, M.; Brödel, A.K.; Quast, R.B.; Sachse, R.; Kubick, S. Cell-free systems: Functional modules for synthetic and chemical biology. In Advances in Biochemical Engineering/ Biotechnology; Springer: Berlin/Heidelberg, Germany, 2013; pp. 67–102.
6. Orth, J.H.C.; Schorcha, B.; Boundy, S.; Ffrench-Constant, R.; Kubick, S.; Aktories, K. Cell-free synthesis and characterization of a novel cytotoxic pierisin-like protein from the cabbage butterfly Pieris rapae. Toxicon 2011, 57, 199–207.
7. Katzen, F.; Peterson, T.C.; Kudlicki, W. Membrane protein expression: No cells required. Trends Biotechnol. 2009, 27, 455–460.
8. Yin, G.; Garces, E.D.; Yang, J.; Zhang, J.; Tran, C.; Steiner, A.R.; Roos, C.; Bajad, S.; Hudak, S.; Penta, K. et al. Aglycosylated antibodies and antibody fragments produced in a scalable in vitro transcription-translation system. mAbs 2012, 4, 217–225.
9. Kawasaki, T.; Gouda, M.D.; Sawasaki, T.; Takai, K.; Endo, Y. Efficient synthesis of a disulfidecontaining protein through a batch cell-free system from wheat germ. Eur. J. Biochem. 2003, 270, 4780–4786.
10. Stech, M.; Hust, M.; Schulze, C.; Dübel, S.; Kubick, S. Cell-free eukaryotic systems for the production, engineering and modification of scFv antibody fragments. Eng. Life Sci. 2014, 14, 387–398.
11. Köhler, G.; Milstein, C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 1975, 256, 495–497.
12. Presta, L.G. Engineering of therapeutic antibodies to minimize immunogenicity and optimize function. Adv. Drug Deliver. Rev. 2006, 58, 640–656.
13. Weisser, N.E.; Hall, J.C. Applications of single-chain variable fragment antibodies in therapeutics and diagnostics. Biotechnol. Adv. 2009, 27, 502–520.
14. Huston, J.S.; Levinson, D.; Mudgett-Hunter, M.; Tai, M.S.; Novotný, J.; Margolies, M.N.; Ridge, R.J.; Bruccoleri, R.E.; Haber, E.; Crea, R. Protein engineering of antibody binding sites: Recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli. Proc. Natl. Acad. Sci. USA 1988, 85, 5879–5883.
15. Bird, R.E.; Hardman, K.D.; Jacobson, J.W.; Johnson, S.; Kaufman, B.M.; Lee, S.M.; Lee, T.; Pope, S.H.; Riordan, G.S.; Whitlow, M. Single-chain antigen-binding proteins. Science 1988, 242, 423–426.
16. Mccafferty, J.; Griffiths, A.D.; Winter, G.; Chiswell, D.J. Phage antibodies: Filamentous phage displaying antibody variable domain. Nature 1990, 348, 552–554.
17. Smith, G. Filamentous fusion phage: Novel expression vectors that display cloned antigens on the virion surface. Science 1985, 228, 1315–1317.
18. Barbas, C.F., 3rd; Kang, A.S.; Lerner, R.A.; Benkovic, S.J. Assembly of combinatorial antibody libraries on phages surfaces: The III gene site. Proc. Natl. Acad. Sci. USA 1991, 88, 7987–7982.
19. Barbas, C.; Lerner, R. Combinatorial immunoglobulin libraries on the surface of phage (Phabs): Rapid selection of antigen-specific Fabs. Methods 1991, 2, 119–124.
20. Hust, M.; Dübel, S. Mating antibody phage display to proteomics. Trends Biotechnol. 2004, 22, 8–14.
21. Francisco, J.A.; Campbell, R.; Iverson, B.L.; Georgiou, G. Production and fluorescence-activated cell sorting of Escherichia coli expressing a functional antibody fragment on the external surface. Proc. Natl. Acad. Sci. USA 1993, 90, 10444–10448.
22. Boder, E.T.; Wittrup, K.D. Yeast surface display for screening combinatorial polypeptide libraries. Nat. Biotechnol. 1997, 15, 553–557.
23. Roberts, R.; Szostak, J. RNA-peptide fusions for the in vitro selection of peptides and proteins Proc. Natl. Acad. Sci. USA 1997, 94, 12297–12302.
24. Nemoto, N.; Miyamoto-Sato, E.; Husimi, Y.; Yanagawa, H. In vitro virus: Bonding of mRNA bearing puromycin at the 3'-terminal end to the C-terminal end of its encoded protein on the ribosome in vitro. FEBS Lett. 1997, 414, 405–408.
25. He, M.; Taussig, M.J. Antibody-ribosome-mRNA (ARM) complexes as efficient selection particles for in vitro display and evolution of antibody combining sites. Nucleic Acids Res. 1997, 25, 5132–5134.
26. Hanes, J.; Plückthun, A. In vitro selection and evolution of functional proteins by using ribosome display. Proc. Natl. Acad. Sci. USA 1997, 94, 4937–4942.
27. Better, M.; Chang, C.P.; Robinson, R.R.; Horwitz, A.H. Escherichia coli secretion of an active chimeric antibody fragment. Science 1988, 240, 1041–1043.
28. Skerra, A.; Plückthun, A. Assembly of a functional immunoglobulin Fv fragment in Escherichia coli. Science 1988, 240, 1038–1041.
29. Carter, P.; Kelley, R.F.; Rodrigues, M.L.; Snedecor, B.; Covarrubias, M.; Velligan, M.D.; Wong, W.L.T.; Rowland, A.M.; Kotts, C.E.; Carver M.E et al. High Level Escherichia coli Expression and Production of a Bivalent Humanized Antibody Fragment. Nat. Biotechnol. 1992, 10, 163–167.
30. Simmons, L.C.; Reilly, D.; Klimowski, L.; Shantha Raju, T.; Meng, G.; Sims, P.; Hong, K.; Shields, R.L.; Damicof, L.A.; Rancatoreg, P. et al. Expression of full-length immunoglobulins in Escherichia coli: rapid and efficient production of aglycosylated antibodies. J. Immunol. Methods 2002, 263, 133–147.
31. Martin, C.; Rojas, G.; Mitchell, J.N.; Vincent, K.J.; Wu, J.; McCafferty, J.; Schofield, D.J. A simple vector system to improve performance and utilization of recombinant antibodies. BMC Biotechnol. 2006, 6, 46.
32. Hackel, B.; Huang, D.; Bubolz, J.C.; Wang, X.X.; Shusta, E.V. Production of soluble and active transferrin receptor-targeting single-chain antibody using Saccharomyces cerevisiae. Pharm. Res. 2006, 23, 790–797.
33. Ren, F.; Li, B.-C.; Zhang, N.-N.; Cao, M.; Dan, W.-B.; Zhang, S.-Q. Expression, purification and characterization of anti-BAFF antibody secreted from the yeast Pichia pastoris. Biotechnol. Lett. 2008, 30, 1075–1080.
34. Bruenke, J.; Fischer, B.; Barbin, K.; Schreiter, K.; Wachter, Y.; Mahr, K.; Titgemeyer, F.; Niederweis, M.; Peipp, M.; Zunino, S.J. et al. A recombinant bispecific single-chain Fv antibody against HLA class II and FcγRIII (CD16) triggers effective lysis of lymphoma cells. Br. J. Haematol. 2004, 125, 167–179.
35. Mayfield, S.P.; Franklin, S.E.; Lerner, R.A. Expression and assembly of a fully active antibody in algae. Proc. Natl. Acad. Sci. USA 2003, 100, 438–442.
36. Makvandi-Nejad, S.; McLean, M.D.; Hirama, T.; Almquist, K.C.; MacKenzie, C.R.; Hall, J.C. Transgenic tobacco plants expressing a dimeric single-chain variable fragment (scfv) antibody against Salmonella enterica serotype Paratyphi B. Transgenic. Res. 2005, 14, 785–792.
37. Natsume, A.; Wakitani, M.; Yamane-Ohnuki, N.; Shoji-Hosaka, E.; Niwa, R.; Uchida, K.; Satoh, M.; Shitara, K. Fucose removal from complex-type oligosaccharide enhances the antibody-dependent cellular cytotoxicity of single-gene-encoded bispecific antibody comprising of two single-chain antibodies linked to the antibody constant region. J. Biochem. 2006, 140, 359–368.
38. Davies, S.; James, D. Production of recombinant monoclonal antibodies in mammalian cells. In Cell Engineering; Al-Rubeai, M., Ed.; Springer: New York, NY, USA, 2009; Volume 6.
39. Li, F.; Shen A.; Amanullah, A. Cell culture processes for monoclonal antibody production. Pharm. Sci. 2013, 1–38.
40. Wurm, F.M. Production of recombinant protein therapeutics in cultivated mammalian cells. Nat. Biotechnol. 2004, 22, 1393–1398.
41. Birch, J.R.; Racher, A.J. Antibody production. Adv. Drug Deliver. Rev. 2006, 58, 671–685.
42. Pedersen, A.; Hellberg, K.; Enberg, J.; Karlsson, B.G. Rational improvement of cell-free protein synthesis. New Biotechnol. 2010, 28, 218–224.
43. Nirenberg, M.; Matthaei, J. The dependence of cell-free protein synthesis in E. coli upon naturally occurring or synthetic polyribonucleotides. Proc. Natl. Acad. Sci. USA 1961, 47, 1588–1602.
44. Bechlars, S.; Wüstenhagen, D.A.; Drägert, K.; Dieckmann, R.; Strauch, E.; Kubick, S. Cell-free synthesis of functional thermostable direct hemolysins of Vibrio parahaemolyticus. Toxicon 2013, 76, 132–142.
45. Griffiths, A.D.; Tawfik, D.S. Directed evolution of an extremely fast phosphotriesterase by in vitro compartmentalization. EMBO J. 2003, 22, 24–35.
46. Schwarz, D.; Klammt, C.; Koglin, A.; Löhr, F.; Schneider, B.; Dötsch, V.; Bernhard, F. Preparative scale cell-free expression systems: New tools for the large scale preparation of integral membrane proteins for functional and structural studies. Methods 2007, 41, 355–369.
47. Carlson, E.D.; Gan, R.; Hodgman, C.E.; Jewett, M.C. Cell-free protein synthesis: Applications come of age. Biotechnol. Adv. 2012, 30, 1185–1194.
48. Davies, D.; Padlan, E.; Sheriff, S. Antibody-antigen complexes. Annu. Rev. Biochem. 1990, 59, 439–473.
49. Glockshuber, R.; Schmidt, T.; Plückthun, A. The disulfide bonds in antibody variable domains: Effects on stability, folding in vitro, and functional expression in Escherichia coli. Biochemistry 1992, 31, 1270–1279.
50. Goto, Y.; Hamaguchi, K. The role of the intrachain disulfide bond in the conformation and stability of the constant fragment of the immunoglobulin light chain. J. Biochem. 1979, 86, 1433–1441.
51. Kim, D.-M.; Swartz, J.R. Efficient production of a bioactive, multiple disulfide-bonded protein using modified extracts of Escherichia coli. Biotechnol. Bioeng. 2004, 85, 122–129.
52. Bundy, B.C.; Swartz, J.R. Efficient disulfide bond formation in virus-like particles. J. Biotechnol. 2011, 154, 230–239.
53. Katzen, F.; Chang, G.; Kudlicki, W. The past, present and future of cell-free protein synthesis. Trends Biotechnol. 2005, 23, 150–156.
54. Ryabova, L.A.; Desplancq, D.; Spirin, A.S.; Plückthun, A. Functional antibody production using cell-free translation: Effects of protein disulfide isomerase and chaperones. Nat. Biotechnol. 1997, 15, 79–84.
55. Merk, H.; Stiege, W.; Tsumoto, K.; Kumagai, I.; Erdmann, V.A. Cell-free expression of two single-chain monoclonal antibodies against lysozyme: Effect of domain arrangement on the expression. J. Biochem. (Tokyo) 1999, 125, 328–333.
56. Jiang, X.; Ookubo, Y.; Fujii, I.; Nakano, H.; Yamane, T. Expression of Fab fragment of catalytic antibody 6D9 in an Escherichia coli in vitro coupled transcription/translation system. FEBS Lett. 2002, 514, 290–294.
57. Yin, G.; Swartz, J.R. Enhancing multiple disulfide bonded protein folding in a cell-free system. Biotechnol. Bioeng. 2004, 86, 188–195.
58. Oh, I.-S.; Kim, D.-M.; Kim, T.-W.; Park, C.-G.; Choi, C.-Y. Providing an oxidizing environment for the cell-free expression of disulfide-containing proteins by exhausting the reducing activity of Escherichia coli S30 extract. Biotechnol. Progr. 2006, 22, 1225–1228.
59. Goerke, A.R.; Swartz, J.R. Development of cell-free protein synthesis platforms for disulfide bonded proteins. Biotechnol. Bioeng. 2008, 99, 351–367.
60. Knapp, K.G.; Goerke, A.R.; Swartz, J.R. Cell-free synthesis of proteins that require disulfide bonds using glucose as an energy source. Biotechnol. Bioeng. 2007, 97, 901–908.
61. Groff, D.; Armstrong, S.; Rivers, P.J.; Zhang, J.; Yang, J.; Green, E.; Rozzelle, J.; Liang, S.; Kittle, J.D.; Steiner, A.R. et al. Engineering toward a bacterial "endoplasmic reticulum" for the rapid expression of immunoglobulin proteins. mAbs 2014, 6, 671–678.
62. Bulleid, N.J.; Bassel-Duby, R.S.; Freedman, R.B.; Sambrook, J.F.; Gething, M.J. Cell-free synthesis of enzymically active tissue-type plasminogen activator. Protein folding determines the extent of N-linked glycosylation. Biochem. J. 1992, 286, 275–280.
63. Ezure, T.; Suzuki, T.; Shikata, M.; Ito, M.; Ando, E.; Nishimura, O.; Tsunasawa, S. Expression of proteins containing disulfide bonds in an insect cell-free system and confirmation of their arrangements by MALDI-TOF MS. Proteomics 2007, 24, 4424–4434.
64. Kubick, S.; Schacherl, J.; Fleischer-Notter, H.; Royall, E.; Roberts, L.O.; Stiege, W. In Vitro translation in an insect-based cell-free system. In Cell-Free Protein Expression; Swartz, J.R., Ed.; Springer: Berlin, Germany, 2003; pp. 209–217.
65. Kubick, S.; Gerrits, M.; Merk, H.; Stiege, W.; Erdmann, V.A. In vitro synthesis of posttranslationally modified membrane proteins. In "Membrane Protein Crystallization" Current Topics in Membranes; DeLucas, L., Ed.; Elsevier: Burlington, Canada, 2009; Chapter 2, pp. 25–49.
66. Sachse, R.; Wüstenhagen, D.; Šamalíková, M.; Gerrits, M.; Bier, F.F.; Kubick, S. Synthesis of membrane proteins in eukaryotic cell-free systems. Eng. Life Sci. 2013, 13, 39–48.
67. Dondapati, S.K.; Kreir, M.; Quast, R.B.; Wüstenhagen, D.A.; Brüggemann, A.; Fertig, N.; Kubick, S. Membrane assembly of the functional KcsA potassium channel in a vesicle-based eukaryotic cell-free translation system. Biosens. Bioelectron. 2014, 59, 174–183.
68. Stech, M.; Quast, R.B.; Sachse, R.; Schulze, C.; Wüstenhagen, D.A.; Kubick, S. A continuousexchange cell-free protein synthesis system based on extracts from cultured insect cells. PLoS One 2014, 9, e96635.
69. Schulze-Gahmen, U.; Rini, J.M.; Wilson, I.A. Detailed Analysis of the Free and Bound Conformations of an Antibody: X-ray Structures of Fab 17/9 and Three Different Fab-peptide Complexes. J. Mol. Biol. 1993, 234, 1098–1118.
70. Han, Y.; Haun, Y.; Deng, J.; Gao, F.; Pan, B.; Cui, D. Expression of Single-Chain Fv Gene Specific for gamma-Seminoprotein by RTS and Its Biological Activity Identification. Biotechnol. Prog. 2006, 22, 1084–1089.
71. Galeffi, P.; Lombardi, A.; Pietraforte, I.; Novelli, F.; Donato, M.D.; Sperandei, M.; Tornambé, A.; Fraioli, R.; Martayan, A.; Natali, P.G. et al. Functional expression of a single-chain antibody to ErbB-2 in plants and cell-free systems. J. Transl. Med. 2006, 4, 39.
72. Miyashita, H.; Hara, T.; Tanimura, R.; Fukuyama, S.; Cagnon, C.; Kohara, A.; Fujii, I. Sitedirected mutagenesis of active site contact residues in a hydrolytic abzyme: Evidence for an essential histidine involved in transition state stabilization. J. Mol. Biol. 1997, 267, 1247–1257.
73. Miyashita, H.; Karaki, Y.; Kikuchi, M.; Fujii, I. Prodrug activation via catalytic antibodies. Proc. Natl. Acad. Sci. USA 1993, 90, 5337–5340.
74. Ali, M.; Suzuki, H.; Fukuba, T.; Jiang, X.; Nakano, H.; Yamane, T. Improvements in the cell-free production of functional antibodies using cell extract from protease-deficient Escherichia coli mutant. J. Biosci. Bioeng. 2005, 99, 181–186.
75. Oh, I.-S.; Lee, J.-C.; Lee, M.-S.; Chung, J.-H.; Kim, D.-M. Cell-free production of functional antibody fragments. Bioproc. Biosyst. Eng. 2010, 33, 127–132.
76. Frey, S.; Haslbeck, M.; Hainzl, O.; Buchner, J. Synthesis and characterization of a functional intact IgG in a prokaryotic cell-free expression system. Biol. Chem. 2008, 389, 37–45.
77. Stafford, R.L.; Matsumoto, M.L.; Yin, G.; Cai, Q.; Fung, J.J.; Stephenson, H.; Gill, A.; You, M.; Lin, S.-H.; Wang, W.D. et al. In vitro Fab display: A cell-free system for IgG discovery. Protein Eng. Des. Sel. 2014, 27, 97–109.
78. Hillebrecht, J.R.; Chong, S. A comparative study of protein synthesis in in vitro systems: From the prokaryotic reconstituted to the eukaryotic extract-based. BMC Biotechnol. 2008, 8, 1790–1793.
79. Langlais, C.; Guilleaume, B.; Wermke, N.; Scheuermann, T.; Ebert, L.; LaBaer, J.; Korn, B. A systematic approach for testing expression of human full-length proteins in cell-free expression systems. BMC Biotechnol. 2007, 7, 1–11.
80. Tarui, H.; Murata, M.; Tani, I.; Imanishi, S.; Nishikawa, S.; Hara, T. Establishment and characterization of translation/glycosylation in insect cell (Spodoptera frugiperda 21) extract prepared with high pressure treatment. Appl. Microbiol. Biotechnol. 2001, 55, 446–453.
81. Chen, R.H.; Huang, C.-J.; Newton, B.S.; Ritter, G.; Old, L.J.; Batt, C.A. Factors affecting endotoxin removal from recombinant therapeutic proteins by anion exchange chromatography. Protein Exp. Purif. 2009, 64, 76–81.
82. Gusdon, J.P.J.; Stavitsky, A.B.; Armentrout, S.A. Synthesis of gamma G antibody and immunoglobulin on polyribosomes in a cell-free system. Proc. Natl. Acad. Sci. USA 1967, 58, 1189–1196.
83. Vassalli, P. Studies on cell-free synthesis of rat immunoglobulins, I. A cell-free system for protein synthesis prepared from lymph-node microsomal vesicles. Proc. Natl. Acad. Sci. USA 1967, 58, 2117–2124.
84. Vassalli, P.; Lisowska-Bernstein, B.; Lamm, M.E.; Benacerraf, B. Studies on cell-free synthesis of rat immunoglobulins, II. Synthesis of immunoglobulin and of antibody to the dinitrophenyl hapten. Proc. Natl. Acad. Sci. USA 1967, 58, 2422–2429.
85. Nicholls, P.J.; Johnson, V.G.; Andrew, S.M.; Hoogenboom, H.R.; Raus, J.C.; Youle, R.J. Characterization of single-chain antibody (sFv)-toxin fusion proteins produced in vitro in rabbit reticulocyte lysate. J. Biol. Chem. 1993, 268, 5302–5308.
86. Hanes, J.; Jermutus, L.; Schaffitze, C.; Plückthun, A. Comparison of Escherichia coli and rabbit reticulocyte ribosome display systems. FEBS Lett. 1999, 450, 105–110.
87. Stech, M.; Merk, H.; Schenk, J.A.; Stöcklein, W.F.M.; Wüstenhagen, D.A.; Micheel, B.; Duschl, C.; Bier, F.F.; Kubick, S. Production of functional antibody fragments in a vesicle-based eukaryotic cell-free translation system. J. Biotechnol. 2012, 164, 220–231.
88. Schenk, J.A.; Sellrie, F.; Böttger, V.; Menning, A.; Stöcklein, W.F.M.; Micheel, B. Generation and application of a fluorescein-specific single chain antibody. Biochimie 2007, 89, 1304–1311.
89. Micheel, B.; Janstcheff, P.; Böttger, V.; Scharte, G.; Kaiser, G.; Stolley, P.; Karawajew, L. The production and radioimmunoassay application of monoclonal antibodies to fluorescein isothiocyanate (FITC). J. Immunol. Methods 1988, 111, 89–94.
90. Merk, H.; Gless, C.; Maertens, B.; Gerrits, M.; Stiege, W. Cell-free synthesis of functional and endotoxin-free antibody Fab fragments by translocation into microsomes. BioTechniques 2012, 53, 153–160.
91. Tu, T.; Weissman, J. Oxidative protein folding in eukaryotes mechanisms and consequences. J. Cell Biol. 2004, 164, 341–346.
92. Kapanidis, A.N.; Weiss, S. Fluorescent probes and bioconjugation chemistries for single-molecule fluorescence analysis of biomolecules. J. Chem. Phys. 2002, 117, 10953–10964.
93. Elvira, C.; Gallardo, A.; Roman, J.; Cifuentes, A. Covalent polymer-drug conjugates. Molecules 2005, 10, 114–125.
94. Kanter, G.; Yang, J.; Voloshin, A.; Levy, S.; Swartz, J.R.; Levy, R. Cell-free production of scFv fusion proteins: An efficient approach for personalized lymphoma vaccines. Blood 2007, 109, 3393–3399.
95. Patel, K.G.; Ng, P.P.; Levy, S.; Levy, R.; Swartz, J.R. Escherichia coli-based production of a tumor idiotype antibody fragment - tetanus toxin fragment C fusion protein vaccine for B cell lymphoma. Protein Exp. Purif. 2011, 75, 15–20.
96. Shimizu, Y.; Kuruma, Y.; Ying, B.-W.; Umekage, S.; Ueda, T. Cell-free translation systems for protein engineering. FEBS J. 2006, 273, 4133–4140.
97. Gerrits, M.; Strey, J.; Claußnitzer, I.; von Groll, U.; Schäfer, F.; Rimmele, M.; Stiege, W. Cell- Free synthesis of defined protein conjugates by site-directed cotranslational labeling. In Cell-free Protein Expression; Kudlicki, T., Katzen, F., Bennett, R., Eds.; Landes Bioscience: Austin, TX, USA, 2007.
98. Budisa, N. Prolegomena to future experimental efforts on genetic code engineering by expanding its amino acid repertoire. Angew. Chem. Int. Ed. 2004, 43, 6426–6463.
99. Service, R.F. Unnatural amino acid could prove boon for protein therapeutics. Science 2005, 308, 44.
100. Mendel, D.; Cornish, V.; Schultz, P. Site-directed mutagenesis with an expanded genetic code. Annu. Rev. Biophys. Biomol. Struct. 1995, 24, 435–462.
101. Kurzchalia, T.V.; Wiedmann, M.; Breter, H.; Zimmermann, W.; Bauschke, E.; Rapoport, T.A. tRNA-mediated labelling of proteins with biotin. A nonradioactive method for the detection of cell-free translation products. Eur. J. Biochem. 1988, 172, 663–668.
102. Liu, C.C.; Schultz, P.G. Adding new chemistries to the genetic code. Annu. Rev. Biochem. 2010, 79, 413–444.
103. Quast, R.B.; Claussnitzer, I.; Merk, H.; Kubick, S.; Gerrits, M. Synthesis and site-directed fluorescence labeling of azido proteins using eukaryotic cell-free orthogonal translation systems. Anal. Biochem. 2014, 451, 4–9.
104. Wang, K.; Schmied, W.H.; Chin, J.W. Reprogramming the genetic code: From triplet to quadruplet codes. Angew. Chem. Int. Ed. 2012, 51, 2288–2297.
105. Sisido, M.; Ninomiya, K.; Ohtsuki, T.; Hohsaka, T. Four-base codon/anticodon strategy and non-enzymatic aminoacylation for protein engineering with non-natural amino acids. Methods 2005, 36, 270–278.
106. Patel, K.G.; Ng, P.P.; Kuo, C.-C.; Levy, S.; Levy, R.; Swartz, J.R. Cell-free production of Gaussia princeps luciferase—antibody fragment bioconjugates for ex vivo detection of tumor cells. Biochem. Biophys. Res. Commun. 2009, 390, 971–976.
107. Hallam, T.; Smider, V. Unnatural amino acids in novel antibody conjugates. Future Med. Chem. 2014, 6, 1309–1324.
108. Zimmerman, E.S.; Heibeck, T.H.; Gill, A.; Li, X.; Murray, C.J.; Madlansacay, M.R.; Tran, C.; Uter, N.T.; Yin, G.; Rivers, P.J. et al. Production of site-specific antibody-drug conjugates using optimized non-natural amino acids in a cell-free expression system. Bioconjug. Chem. 2014, 25, 351–361.
109. Matsuda, T.; Furumoto, S.; Higuchi, K.; Yokoyama, J.; Zhang, M.-R.; Yanai, K.; Iwata, R.; Kigawa, T. Rapid biochemical synthesis of 11C-labeled single chain variable fragment antibody for immuno-PET by cell-free protein synthesis. Bioorg. Med. Chem. 2012, 20, 6579–6582.
110. Brödel, A.K.; Sonnabend, A.; Kubick, S. Cell-free protein expression based on extracts from CHO cells. Biotechnol. Bioeng. 2013, 111, 25–36.
111. Brödel, A.K.; Sonnabend, A.; Roberts, L.O.; Stech, M.; Wüstenhagen, D.A.; Kubick, S. IRESmediated translation of membrane proteins and glycoproteins in eukaryotic cell-free systems. PLoS One 2013, 8, e82234.
112. Ghaderi, D.; Zhang, M.; Hurtado-Ziola, N.; Varki, A. Production platforms for biotherapeutic glycoproteins. Occurrence, impact, and challenges of non-human sialylation. Biotechnol. Genet. Eng. Rev. 2012, 28, 147–175.
113. Shade, K.-T.C.; Anthony, R.M. Antibody Glycosylation and Inflammation. Antibodies 2013, 2, 92–414.
114. Jefferis, R. Glycosylation as a strategy to improve antibody-based therapeutics. Nat. Rev. Drug Discov. 2009, 8, 226–234.
115. Guarino, C.; DeLisa, M. A prokaryote-based cell-free translation system that efficiently synthesizes glycoproteins. Glycobiology 2012, 22, 596–601.
116. Kigawa, T.; Yabuki, T.; Yoshida, Y.; Tsutsui, M.; Ito, Y.; Shibata, T.; Yokoyama, S. Cell-free production and stable-isotope labeling of milligram quantities of proteins. FEBS Lett. 1999, 442, 15–19.
117. Madin, K.; Sawasaki, T.; Ogasawara, T.; Endo, Y. A highly efficient and robust protein synthesis system prepared from wheat embryos: Plants apparently contain a suicide system directed at ribosomes. Proc. Natl. Acad. Sci. USA 2000, 97, 559–564.
118. Ramya, R.; Subramanian, B.M.; Sivakumar, V.; Senthilkumar, R.L.; Rao, K.R.S.S.; Srinivasan, V.A. Expression and solubilization of insect cell-based rabies virus glycoprotein and assessment of its immunogenicity and protective efficacy in mice. Clin. Vaccine Immunol. 2011, 18, 1673–1679.
119. Naftzger, C.; Takechi, Y.; Kohda, H.; Hara, I.; Vijayasaradhi, S.; Houghton, A.N. Immune response to a differentiation antigen induced by altered antigen: A study of tumor rejection and autoimmunity. Proc. Natl. Acad. Sci. USA 1996, 93, 14809–14814.
120. Rostovtsev, V.V.; Green, L.G.; Fokin, V.V.; Sharpless, K.B. A stepwise huisgen cycloaddition process: Copper(I)-catalyzed regioselective “ligation” of azides and terminal alkynes. Angew. Chem. Int. Ed. 2002, 41, 2596–2599.
121. Nguyen, D.P.; Lusic, H.; Neumann, H.; Kapadnis, P.B.; Deiters, A.; Chin, J.W. Genetic encoding and labeling of aliphatic azides and alkynes in recombinant proteins via a pyrrolysyl-tRNA synthetase/tRNACUA pair and click chemistry. J. Am. Chem. Soc. 2009, 131, 8720–8721.
122. Ridgway, J.B.B.; Presta, L.G.; Carter, P. "Knobs-into-holes" engineering of antibody CH3 domains for heavy chain heterodimerization. Protein Eng. 1996, 9, 617–621.
123. Xu, Y.; Lee, J.; Tran, C.; Heibeck, T.H.; Wang, W.D.; Yang, J.; Stafford, R.L.; Steiner, A.R.; Sato, A.K.; Hallam, T.J. et al. Production of bispecific antibodies in "Knobs-into-Holes" using a cell-free expression system. mAbs 2014, doi:10.4161/19420862.2015.989013.
124. Murray, C.J.; Baliga, R. Cell-free translation of peptides and proteins: From high throughput screening to clinical production. Curr. Opin. Chem. Biol. 2013, 17, 420–426.